International - Financial Times - Credit Squeeze

Swiss pharma group in talks with Washington to bypass middlemen and sell directly to consumers

Whoever smelt it dealt it

The rate outlook is solidifying, but trade relief only goes so far

Also in this newsletter: EU simplification savings worth €8.5bn and Zelenskyy’s anti-corruption power grab

Planned five-day walkout marks sharp escalation in BMA’s dispute with the government as row over pay drags on

The discipline is failing students by ignoring the biggest social, political and ecological challenges facing the world today

Donald Trump’s tariff threat to Lesotho shows the danger of relying on preferential trade access

Uncertainty around levies weigh on Mattel and Hasbro

New menu items help to slightly boost growth in foot traffic during the second quarter

But is anyone listening?

Congress cannot afford to allow the Defense Production Act to expire

Six months in, the negative effects of the US president’s plans are only starting to be felt